by Peter Gorne | May 30, 2023 | Press Release
The FDA grants the Delphi-MD device breakthrough designation technology status for the diagnosis of Normal Pressure Hydrocephalus (NPH) patients and prediction of response to highly effective, ventriculoperitoneal shunting surgery (VPS) treatment. KFAR SABA, Israel,... by Peter Gorne | Feb 9, 2023 | Press Release
QuantalX’s direct electrophysiology imaging technology (Delphi-MD) expected to provide multiple clinically objective and accurate measurements in NeuroSense’s Phase 2 double-blind proof-of-concept clinical study in Alzheimer’s disease, expected to... by Peter Gorne | Nov 14, 2022 | Press Release
Delphi-MD, World’s first direct brain network visualization technology showcasing at the HLTH Las Vegas conference today, provides objective clinical measurements of neuronal functions for the first time, enabling point of care physicians and neurologists access... by Peter Gorne | Nov 8, 2021 | Press Release
The collaboration will apply QuantalX’s breakthrough device Delphi·MD™ technology to develop a comprehensive database relating to psychedelic substance effects on the brain Drug development company IMIO life ltd. (“IMIO”), a company dedicated to the development of...